You are here


Board Statements

ESSCB Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras

On November 14, 2011, the ESSCB Funding Committee voted to adopt a Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras, which was developed and...

read more

ESSCB Statement on the Compensation of Oocyte Donors

June 11, 2009 -- The ESSCB adopted a resolution regarding the compensation of women donating oocytes solely for research purposes and issued a statement...

read more

ESSCB Board Comments on NIH Draft Guidelines

May 26, 2009 -- The Empire State Stem Cell Board today submitted comments to the National Institutes of Health on NIH's Draft Guidelines for Human Stem Cell Research.


read more

New Model Informed Consent Forms

ESSCB Model Informed Consent Forms On November 14, 2011, the ESSCB Funding Committee approved five model informed consent forms developed by the ESSCB Ethics Committee. The forms provide guidance...

read more

News Releases

Patient Cells Yield Potential Therapies For Familial Dysautonomia

Lorenz Studer reports the first large-scale drug discovery screen based on an iPSC-derived disease model.

read more

Two NYSTEM-funded Scientists Elected as Fellows to AAAS

Drs. Shahin Rafii and Ming-Ming Zhou were elected as Fellows of the American Association for the Advancement of Science.

read more

The Ubiquitin-Proteasome System Adds Complexity to Pluripotency and Reprogramming

New data from Iannis Aifantis shows the Ubiquitin-Proteasome System functions in both reprogramming and differentiation of pluripotent stem cells, partially through targeting of c-Myc.

read more

Amniotic Fluid Cells Reprogrammed to Endothelial Cells

Shahin Rafii reports the efficient direct conversion of amniotic fluid-derived cells into functional vascular endothelial cells.

read more

Gene Therapy for α-Thalassemia in iPS Cells

Dr. Eric Bouhassira reports zinc finger nuclease-mediated gene correction for α-thalassemia in patient iPSCs.

read more

Molecular Mechanisms of Reprogramming Unveiled

New research from Dr. Asa Abeliovich provides insight to the molecular mechanisms of reprogramming.

read more

Identification of a Key Regulatory Factor in Hematopoiesis and Cancer

New data from Dr. Ulrich Steidl identifies a key transcription factor that regulates hematopoiesis and promotes acute myeloid leukemia.

read more

Novel Gene Sets Identified that Regulate the Survival of Leukemia Stem Cells

Leukemia stem cells (LSCs) represent a biologically distinct subpopulation of myeloid leukemias, with reduced cell cycle activity and increased resistance to therapeutic challenge.

read more

A New Method to Improve the Yield of RBCs Over 100-fold

Eric Bouhassira’s group defines a method to improve the yield of RBCs over 100-fold. RBCs are critical for blood transfusions in surgeries, trauma care, and blood diseases such as sickle cell disease. Dr. Bouhassira and colleagues at the Albert Einstein College of Medicine combined several different methodologies to increase the number of RBCs in a sample by over 100-fold, and can envisage significant further improvements.

read more

FDA Approves Trial of Stem Cell-Based Gene Therapy for Blood Disease

Dr. Michel Sadelain leads a team developing a potential cure for β-thalassemia.

read more